Clinical Trial Update: Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update on recombinant zoster vaccine to prevent herpes zoster in young adult solid organ transplant recipients; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Varicella Zoster | Phase 4 | Status: ENROLLING_BY_INVITATION